Clinical Trial Update: TACE Versus HAIC, Combined With PD-1 Inhibitors and Lenvatinib for Unresectable Hepatocellular Carcinoma

View source ↗

Summary

A clinical trial comparing transarterial chemoembolization and hepatic arterial infusion chemotherapy, each combined with PD-1 inhibitors and lenvatinib, for un…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Lenvatinib (lenvatinib)
• PD-1 inhibitors

Snippet

Sponsor: Tongji Hospital | Conditions: HCC | Status: NOT_YET_RECRUITING